Issue 6/2002
Content (11 Articles)
Online First publication
α-Adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with α-adrenoceptor antagonists
Karl-Erik Andersson
Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia
G. Bartsch, R. Rittmaster, H. Klocker
The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia
Kurt Dreikorn
Future drugs for the treatment of benign prostatic hyperplasia
Karl-Erik Andersson, C. R. Chapple, K. Höfner
Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men
Matthias Oelke, Klaus Höfner, Birgitt Wiese, Volker Grünewald, Udo Jonas
The influence of obstructive interval on patency rates following microsurgical epididymovasostomy
Richard A. Schoor, Samir M. Elhanbly, Lawrence S. Ross, Craig S. Niederberger
In vivo effect of the lipido-sterolic extract of Serenoa repens (Permixon) on mast cell accumulation and glandular epithelium trophism in the rat prostate
Dionisios Mitropoulos, Aspasia Kyroudi, Anastasios Zervas, Stefanos Papadoukakis, Aris Giannopoulos, Christos Kittas, Panagiotis Karayannacos
Erratum to: Systemic and cavernous plasma levels of endothelin (1–21) during different penile conditions in healthy males and patients with erectile dysfunction
Armin J. Becker, Stefan Ückert, Christian G. Stief, Michael C. Truss, Uwe Hartmann, Udo Jonas